"

From 2014.igem.org

Revision as of 17:59, 17 September 2014 (view source) Denalirao (Talk | contribs) ← Older edit		Revision as of 18:53, 17 September 2014 (view source) Denalirao (Talk | contribs) Newer edit →
Line 65:		Line 65:
	<a href = "https://2014.igem.org/Team:Tufts/Project#methods"><h5>Jump to Methods</h5></a>		<a href = "https://2014.igem.org/Team:Tufts/Project#methods"><h5>Jump to Methods</h5></a>
	<h2> Summaries </h2>		<h2> Summaries </h2>
		+
		+	<tr> <td width="100%">
		+	<h3>Robust biofilm formation using a cyclic-di-GMP aptamer and investigating ethics and applications of engineered bactiophage</h3>
		+	A long, noncoding massively expressed regulatory RNA (merRNA) discovered in Bdellovibrio
		+	bacteriovorus is present in high levels during its dormant phase. The merRNA is believed to sequester
		+	cyclic-di-GMP, much like a sponge. Since cyclic-di-GMP is a second messenger for various cellular
		+	functions, including motility and biofilm formation, the Tufts iGEM team introduced this merRNA
		+	sequence into E. coli. Constitutive expression of this merRNA transcript was shown to increase biofilm
		+	formation. This property can be useful in microbe-based approaches to environmental remediation.
		+	Earlier designs for phage delivery of the merRNA to disrupt biofilms inspired an investigation into the
		+	policy surrounding engineered bacteriophage. Tufts iGEM will be convening a panel of experts from
		+	various disciplines to put forth recommendations for the responsible use of phage in therapeutic and
		+	industrial applications. A proposal will be drafted for a silk bandage containing a phage cocktail which
		+	can prevent and treat infection by antibiotic-resistant bacteria.
		+	</td></tr>
		+
	<p> <h3>Ribosponge Project Description:</h3>		<p> <h3>Ribosponge Project Description:</h3>
Line 110:		Line 126:
	<br><br>		<br><br>
	-->		-->
-	<tr> <td width="100%">
-	<h3>Robust biofilm formation using a cyclic-di-GMP aptamer and investigating ethics and applications of engineered bactiophage</h3>
-	A long, noncoding massively expressed regulatory RNA (merRNA) discovered in Bdellovibrio
-	bacteriovorus is present in high levels during its dormant phase. The merRNA is believed to sequester
-	cyclic-di-GMP, much like a sponge. Since cyclic-di-GMP is a second messenger for various cellular
-	functions, including motility and biofilm formation, the Tufts iGEM team introduced this merRNA
-	sequence into E. coli. Constitutive expression of this merRNA transcript was shown to increase biofilm
-	formation. This property can be useful in microbe-based approaches to environmental remediation.
-	Earlier designs for phage delivery of the merRNA to disrupt biofilms inspired an investigation into the
-	policy surrounding engineered bacteriophage. Tufts iGEM will be convening a panel of experts from
-	various disciplines to put forth recommendations for the responsible use of phage in therapeutic and
-	industrial applications. A proposal will be drafted for a silk bandage containing a phage cocktail which
-	can prevent and treat infection by antibiotic-resistant bacteria.
-	</td></tr>
	<tr> <td>		<tr> <td>

---

Revision as of 18:53, 17 September 2014

Ribosponge Project Description:

We have devised a method to introduce a DNA sequence which encodes an RNA aptamer (i.e. - an oligonucleotide sequence which binds to a specific molecule) into a non-pathogenic E. coli strain. We have dubbed this RNA aptamer a “ribosponge” due to its unique mode of action. The ribosponge binds cyclic di-GMP, a secondary intracellular messenger which signals bacteria to enter a persistent or biofilm state. The signal is universal among many species such as E. coli, P. aeruginosa, and M. tuberculosis. Blocking the signal of c-di-GMP by binding it with an aptamer could prevent the persistent state in these and other pathogens. In order to ferry the sequence encoding the aptamer from our non-pathogenic E. coli into other bacteria of the same species, we plan on using an M13 phage which does not kill the bacteria. The project has also inspired our collaboration with the Rathneau Institute and SYNENERGENE as we look at the feasability of developing ribosponge into a product, and examine the regulatory, legal, and ethical challenges of packing it into a bacteriophage.

Tufts iGEM 2014

Home Team Official Team Profile Project Parts Modeling Notebook Safety Attributions

Jump to Backgrounds Jump to Methods Summaries

Robust biofilm formation using a cyclic-di-GMP aptamer and investigating ethics and applications of engineered bactiophage A long, noncoding massively expressed regulatory RNA (merRNA) discovered in Bdellovibrio bacteriovorus is present in high levels during its dormant phase. The merRNA is believed to sequester cyclic-di-GMP, much like a sponge. Since cyclic-di-GMP is a second messenger for various cellular functions, including motility and biofilm formation, the Tufts iGEM team introduced this merRNA sequence into E. coli. Constitutive expression of this merRNA transcript was shown to increase biofilm formation. This property can be useful in microbe-based approaches to environmental remediation. Earlier designs for phage delivery of the merRNA to disrupt biofilms inspired an investigation into the policy surrounding engineered bacteriophage. Tufts iGEM will be convening a panel of experts from various disciplines to put forth recommendations for the responsible use of phage in therapeutic and industrial applications. A proposal will be drafted for a silk bandage containing a phage cocktail which can prevent and treat infection by antibiotic-resistant bacteria.

Backgrounds

Methods Sponge Lab Notebook